Effects of anandamide and arachidonic acid on specific binding of (+)-PN200-110, diltiazem and (-)-desmethoxyverapamil to L-type Ca2+ channel

European Journal of Pharmacology

Volumn 296, Issue 3, 1996, Pages 347-350

  Shimasue, Kazuhide ^a   Urushidani, Tetsuro ^a   Hagiwara, Masafumi ^a   Nagao, Taku ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anandamide; Arachidonic acid; Ca2+ channel; 3H (+) PN200 110; 3H ( ) desmethoxyverapamil; 3H diltiazem

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; ANANDAMIDE; ARACHIDONIC ACID; BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL; DEVAPAMIL; DILTIAZEM; INDOMETACIN; ISRADIPINE; NICARDIPINE; PHENYLALKYLAMINE; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RABBIT; SKELETAL MUSCLE;

ANIMALS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DILTIAZEM; ISRADIPINE; MALE; POLYUNSATURATED ALKAMIDES; RABBITS; VERAPAMIL;

EID: 0030060732     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00826-8     Document Type: Article

References (13)

1. 3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil, J. Pharmacol. Exp. Ther. 237, 40.
2. Devane, W.A. and J. Axelrod, 1994, Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes, Proc. Natl. Acad. Sci. USA 91, 6698.
3. Devane, W.A., L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger and R. Mechoulam, 1992, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science 258, 1946.
4. Di Marzo, V., A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.C. Schwartz and D. Piomelli, 1994, Formation and inactivation of endogenous cannabinoid anandamide in central neurons, Nature 372, 686.
5. 3H]-nimodipine. Naunyn-Schmied. Arch. Pharmacol. 323, 279.
6. Glossman, H., D. Ferry, A. Goll, J. Striessnig and G. Zernig, 1985, Calcium channels and calcium channel drugs: recent biochemical and biophysical findings, Arzneim.-Forsch./Drug Res. 35, 1917.
7. Huang, J.M., H. Xian and M. Bacaner, 1992, Long-chain fatty acids activate calcium channels in ventricular myocytes, Proc. Natl. Acad. Sci. USA 44, 6452.
8. 3H]PN200-110 to rabbit T-tubule calcium channels, Eur. J. Pharmacol. Mol. Pharmacol. 208, 199.
9. Johnson, D.E., S.L. Heald, R.D. Dally and R.A. Janis, 1993, Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding, Prostaglandins Leukotrienes Essent. Fatty Acids 48, 429.
10. Kruszka, K.K. and R.W. Gross, 1994, The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor, J. Biol. Chem. 269, 14345.
11. Mackie, K., W.A. Devane and B. Hille, 1993, Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells, Mol. Pharmacol. 44, 498.
12. 3H]azidobutyryl diltiazem, J. Biol. Chem. 264, 21211.
13. 2+, and contraction in adult rat cardiac myocytes, Proc. Natl. Acad. Sci. USA 91, 8832.